{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:57:49Z","timestamp":1790279869337,"version":"4.1.0"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002465","name":"Daejeon University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002465","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jep.2025.120292","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T23:07:06Z","timestamp":1752793626000},"page":"120292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"PA","title":["Injinoryeong-San attenuates metabolic dysfunction-associated steatohepatitis via regulation of YAP\/TAZ-signaling pathway"],"prefix":"10.1016","volume":"353","author":[{"given":"Hyun-Sik","family":"Seo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeong-Geug","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haneum","family":"Joo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihoon","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Hyo","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jep.2025.120292_bib1","article-title":"Cinnamic acid abrogates bisphenol A-induced hepatotoxicity via suppression of pro-inflammatory cytokine and modulation of gene expressions of antioxidant enzymes in rats","volume":"14","author":"Adeyanju","year":"2025","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.jep.2025.120292_bib2","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.intimp.2017.01.016","article-title":"Curcumin ameliorates liver damage and progression of NASH in NASH-HCC mouse model possibly by modulating HMGB1-NF-kappaB translocation","volume":"44","author":"Afrin","year":"2017","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.jep.2025.120292_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10020174","article-title":"Role of oxidative stress in the pathogenesis of non-alcoholic fatty liver disease: implications for prevention and therapy","volume":"10","author":"Arroyave-Ospina","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.jep.2025.120292_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jep.2014.12.023","article-title":"Characterizing the human equivalent dose of herbal medicines in animal toxicity studies","volume":"162","author":"Bae","year":"2015","journal-title":"J. Ethnopharmacol."},{"issue":"4","key":"10.1016\/j.jep.2025.120292_bib5","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1002\/hep.25805","article-title":"Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: a pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow-up study","volume":"56","author":"Bell","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jep.2025.120292_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101143","article-title":"Metabolic drivers of non-alcoholic fatty liver disease","volume":"50","author":"Bence","year":"2021","journal-title":"Mol. Metabol."},{"issue":"4","key":"10.1016\/j.jep.2025.120292_bib7","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/flgastro-2021-101886","article-title":"Guideline review: EASL clinical practice guidelines: drug-induced liver injury (DILI)","volume":"13","author":"Brennan","year":"2022","journal-title":"Frontline Gastroenterol."},{"issue":"12","key":"10.1016\/j.jep.2025.120292_bib8","article-title":"Lipid metabolism in MASLD and MASH: from mechanism to the clinic","volume":"6","author":"Carli","year":"2024","journal-title":"JHEP Rep."},{"key":"10.1016\/j.jep.2025.120292_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113166","article-title":"Roles of Yes-associated protein and transcriptional coactivator with PDZ-binding motif in non-neoplastic liver diseases","volume":"151","author":"Chen","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jep.2025.120292_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105849","article-title":"Traditional Chinese medicine in the treatment of nonalcoholic steatohepatitis","volume":"172","author":"Chen","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jep.2025.120292_bib11","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"152","author":"Chen","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jep.2025.120292_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/srep46658","article-title":"Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients","volume":"7","author":"Chiappini","year":"2017","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.jep.2025.120292_bib13","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202200522R","article-title":"Sirtuin 6 protects against hepatic fibrogenesis by suppressing the YAP and TAZ function","volume":"36","author":"Chowdhury","year":"2022","journal-title":"FASEB J."},{"issue":"51","key":"10.1016\/j.jep.2025.120292_bib14","article-title":"Effectiveness and safety of Injinoryung-San-Gagambang (Yinchen Wuling powder) decoction on stroke patients with elevated serum liver enzymes: three case reports","volume":"97","author":"Chu","year":"2018","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.jep.2025.120292_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.117812","article-title":"Bioactive triterpenoid compounds of Poria cocos (Schw.) Wolf in the treatment of diabetic ulcers via regulating the PI3K-AKT signaling pathway","volume":"325","author":"Ding","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"5","key":"10.1016\/j.jep.2025.120292_bib16","first-page":"505","article-title":"Expression of fatty acid synthase in nonalcoholic fatty liver disease","volume":"3","author":"Dorn","year":"2010","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"2","key":"10.1016\/j.jep.2025.120292_bib17","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.metabol.2013.10.009","article-title":"Palmitate-induced activation of mitochondrial metabolism promotes oxidative stress and apoptosis in H4IIEC3 rat hepatocytes","volume":"63","author":"Egnatchik","year":"2014","journal-title":"Metabolism"},{"issue":"5","key":"10.1016\/j.jep.2025.120292_bib18","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.jhep.2011.09.024","article-title":"Clinical evidence for the regression of liver fibrosis","volume":"56","author":"Ellis","year":"2012","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.jep.2025.120292_bib19","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jhep.2019.02.014","article-title":"EASL Clinical practice guidelines: drug-Induced liver injury","volume":"70","year":"2019","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.jep.2025.120292_bib20","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.jep.2025.120292_bib21","article-title":"Pharmacodynamic effects of direct AMP kinase activation in humans with insulin resistance and non-alcoholic fatty liver disease: a phase 1b study","volume":"2","author":"Fouqueray","year":"2021","journal-title":"Cell Rep. Med."},{"issue":"35","key":"10.1016\/j.jep.2025.120292_bib22","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2405746121","article-title":"Lipid-associated macrophages' promotion of fibrosis resolution during MASH regression requires TREM2","volume":"121","author":"Ganguly","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jep.2025.120292_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155313","article-title":"Alisol B regulates AMPK\/mTOR\/SREBPs via directly targeting VDAC1 to alleviate hyperlipidemia","volume":"128","author":"Gao","year":"2024","journal-title":"Phytomedicine"},{"issue":"6","key":"10.1016\/j.jep.2025.120292_bib24","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/0306-3623(93)90434-Y","article-title":"Protective effect of artemisia scoparia extract against acetaminophen-induced hepatotoxicity","volume":"24","author":"Gilani","year":"1993","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.jep.2025.120292_bib25","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/bs.pmbts.2019.03.012","article-title":"The efficacy of Polyporus umbellatus polysaccharide in treating hepatitis B in China","volume":"163","author":"Guo","year":"2019","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"issue":"6","key":"10.1016\/j.jep.2025.120292_bib26","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.etp.2012.12.002","article-title":"Artemisia capillaris extract protects against bile duct ligation-induced liver fibrosis in rats","volume":"65","author":"Han","year":"2013","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.jep.2025.120292_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115279","article-title":"Advanced effect of curcumin and resveratrol on mitigating hepatic steatosis in metabolic associated fatty liver disease via the PI3K\/AKT\/mTOR and HIF-1\/VEGF cascade","volume":"165","author":"He","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"8","key":"10.1016\/j.jep.2025.120292_bib28","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1111\/jcmm.14380","article-title":"Alisol A attenuates high-fat-diet-induced obesity and metabolic disorders via the AMPK\/ACC\/SREBP-1c pathway","volume":"23","author":"Ho","year":"2019","journal-title":"J. Cell Mol. Med."},{"issue":"1","key":"10.1016\/j.jep.2025.120292_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.psj.2023.103171","article-title":"Immunomodulatory effect of atractylodis macrocephala koidz. polysaccharides in vitro","volume":"103","author":"Hu","year":"2024","journal-title":"Poult. Sci."},{"key":"10.1016\/j.jep.2025.120292_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105170","article-title":"Scoparone as a therapeutic drug in liver diseases: pharmacology, pharmacokinetics and molecular mechanisms of action","volume":"160","author":"Hui","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.jep.2025.120292_bib31","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF02977716","article-title":"Scoparone from Artemisia capillaris inhibits the release of inflammatory mediators in RAW 264.7 cells upon stimulation cells by interferon-gamma plus LPS","volume":"28","author":"Jang","year":"2005","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.jep.2025.120292_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113699","article-title":"The antitumor properties of atractylenolides: molecular mechanisms and signaling pathways","volume":"155","author":"Jiang","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jep.2025.120292_bib33","article-title":"Scoparone improves nonalcoholic steatohepatitis through alleviating JNK\/Sab signaling pathway-mediated mitochondrial dysfunction","volume":"13","author":"Jiang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jep.2025.120292_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110105","article-title":"Anti-hepatofibrotic effects of CGX, a standardized herbal formula: a multicenter randomized clinical trial","volume":"126","author":"Joung","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"11","key":"10.1016\/j.jep.2025.120292_bib35","doi-asserted-by":"crossref","DOI":"10.1172\/JCI151895","article-title":"Inhibiting SCAP\/SREBP exacerbates liver injury and carcinogenesis in murine nonalcoholic steatohepatitis","volume":"132","author":"Kawamura","year":"2022","journal-title":"J. Clin. Investig."},{"issue":"6","key":"10.1016\/j.jep.2025.120292_bib36","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s40265-024-02045-0","article-title":"Resmetirom: first approval","volume":"84","author":"Keam","year":"2024","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.jep.2025.120292_bib37","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jhep.2019.06.019","article-title":"The epigenetic regulator SIRT6 protects the liver from alcohol-induced tissue injury by reducing oxidative stress in mice","volume":"71","author":"Kim","year":"2019","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.jep.2025.120292_bib38","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/s42003-021-02616-x","article-title":"Modelling human liver fibrosis in the context of non-alcoholic steatohepatitis using a microphysiological system","volume":"4","author":"Kostrzewski","year":"2021","journal-title":"Commun. Biol."},{"issue":"1","key":"10.1016\/j.jep.2025.120292_bib39","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.54707","article-title":"Estimated burden of metabolic dysfunction-associated steatotic liver disease in US adults, 2020 to 2050","volume":"8","author":"Le","year":"2025","journal-title":"JAMA Netw. Open"},{"issue":"4","key":"10.1016\/j.jep.2025.120292_bib40","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s10068-022-01042-x","article-title":"Roles of anti- and pro-oxidant potential of cinnamic acid and phenylpropanoid derivatives in modulating growth of cultured cells","volume":"31","author":"Lee","year":"2022","journal-title":"Food Sci. Biotechnol."},{"issue":"4","key":"10.1016\/j.jep.2025.120292_bib41","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s12276-024-01213-2","article-title":"Loss of SREBP-1c ameliorates iron-induced liver fibrosis by decreasing lipocalin-2","volume":"56","author":"Lee","year":"2024","journal-title":"Exp. Mol. Med."},{"issue":"6","key":"10.1016\/j.jep.2025.120292_bib42","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s12272-024-01501-5","article-title":"Interplay between YAP\/TAZ and metabolic dysfunction-associated steatotic liver disease progression","volume":"47","author":"Lee","year":"2024","journal-title":"Arch Pharm. Res. (Seoul)"},{"issue":"1","key":"10.1016\/j.jep.2025.120292_bib43","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12944-024-02108-x","article-title":"Updated mechanisms of MASLD pathogenesis","volume":"23","author":"Li","year":"2024","journal-title":"Lipids Health Dis."},{"issue":"11","key":"10.1016\/j.jep.2025.120292_bib44","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1101\/gad.1903310","article-title":"The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation","volume":"24","author":"Lian","year":"2010","journal-title":"Genes Dev."},{"issue":"14","key":"10.1016\/j.jep.2025.120292_bib45","doi-asserted-by":"crossref","first-page":"4787","DOI":"10.1016\/j.bmcl.2012.05.057","article-title":"Triterpenes from Alisma orientalis act as farnesoid X receptor agonists","volume":"22","author":"Lin","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"10","key":"10.1016\/j.jep.2025.120292_bib46","doi-asserted-by":"crossref","first-page":"7697","DOI":"10.1007\/s00210-024-03046-2","article-title":"Atractylenolide II regulates the proliferation, ferroptosis, and immune escape of hepatocellular carcinoma cells by inactivating the TRAF6\/NF-kappaB pathway","volume":"397","author":"Lin","year":"2024","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"issue":"6","key":"10.1016\/j.jep.2025.120292_bib47","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1073\/pnas.0630588100","article-title":"Triglyceride accumulation protects against fatty acid-induced lipotoxicity","volume":"100","author":"Listenberger","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.jep.2025.120292_bib48","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1101\/gad.192856.112","article-title":"Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP","volume":"26","author":"Liu-Chittenden","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.jep.2025.120292_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155398","article-title":"Efficacy and safety of Qushi Huayu, a traditional Chinese medicine, in patients with nonalcoholic fatty liver disease in a randomized controlled trial","volume":"130","author":"Liu","year":"2024","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.jep.2025.120292_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2017.205","article-title":"Hippo pathway coactivators Yap and Taz are required to coordinate mammalian liver regeneration","volume":"50","author":"Lu","year":"2018","journal-title":"Exp. Mol. Med."},{"issue":"17","key":"10.1016\/j.jep.2025.120292_bib51","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.161282","article-title":"Hepatic FASN deficiency differentially affects nonalcoholic fatty liver disease and diabetes in mouse obesity models","volume":"8","author":"Matsukawa","year":"2023","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.jep.2025.120292_bib52","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/aps.2016.119","article-title":"Alisol B 23-acetate protects against non-alcoholic steatohepatitis in mice via farnesoid X receptor activation","volume":"38","author":"Meng","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"issue":"5","key":"10.1016\/j.jep.2025.120292_bib53","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/hep.30928","article-title":"Hepatocyte stress increases expression of yes-associated protein and transcriptional coactivator with PDZ-binding motif in hepatocytes to promote parenchymal inflammation and fibrosis","volume":"71","author":"Mooring","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jep.2025.120292_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2023.101238","article-title":"Lipidomics in pathogenesis, progression and treatment of nonalcoholic steatohepatitis (NASH): recent advances","volume":"91","author":"Musso","year":"2023","journal-title":"Prog. Lipid Res."},{"issue":"4","key":"10.1016\/j.jep.2025.120292_bib55","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.metabol.2006.11.004","article-title":"Transgenic mice expressing nuclear sterol regulatory element-binding protein 1c in adipose tissue exhibit liver histology similar to nonalcoholic steatohepatitis","volume":"56","author":"Nakayama","year":"2007","journal-title":"Metabolism"},{"key":"10.1016\/j.jep.2025.120292_bib56","doi-asserted-by":"crossref","DOI":"10.1038\/srep17192","article-title":"Astaxanthin prevents and reverses diet-induced insulin resistance and steatohepatitis in mice: a comparison with vitamin E","volume":"5","author":"Ni","year":"2015","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jep.2025.120292_bib57","article-title":"FASN inhibition targets multiple drivers of NASH by reducing steatosis, inflammation and fibrosis in preclinical models","volume":"12","author":"O'Farrell","year":"2022","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.jep.2025.120292_bib58","first-page":"641","article-title":"Vitamin E and nonalcoholic fatty liver disease","volume":"15","author":"Pacana","year":"2012","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.jep.2025.120292_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2023.101231","article-title":"Liver fibrosis in NAFLD\/NASH: from pathophysiology towards diagnostic and therapeutic strategies","volume":"95","author":"Parola","year":"2024","journal-title":"Mol. Aspect. Med."},{"issue":"1","key":"10.1016\/j.jep.2025.120292_bib60","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1124\/jpet.122.001301","article-title":"Cinnabarinic acid provides hepatoprotection against nonalcoholic fatty liver disease","volume":"383","author":"Patil","year":"2022","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"13","key":"10.1016\/j.jep.2025.120292_bib61","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.4254\/wjh.v7.i13.1761","article-title":"Drug- and herb-induced liver injury: progress, current challenges and emerging signals of post-marketing risk","volume":"7","author":"Raschi","year":"2015","journal-title":"World J. Hepatol."},{"issue":"10","key":"10.1016\/j.jep.2025.120292_bib62","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/apt.17958","article-title":"Prevalence of at-risk MASH, MetALD and alcohol-associated steatotic liver disease in the general population","volume":"59","author":"Schneider","year":"2024","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.jep.2025.120292_bib63","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1053\/j.gastro.2019.11.311","article-title":"Mechanisms of fibrosis development in nonalcoholic steatohepatitis","volume":"158","author":"Schwabe","year":"2020","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.jep.2025.120292_bib64","doi-asserted-by":"crossref","first-page":"8567","DOI":"10.1007\/s00210-025-03789-6","article-title":"Liraglutide mitigates dexamethasone-induced fatty acid synthase (FASN) and the cluster of differentiation36 (CD36) expression: a potential treatment for glucocorticoid-induced non-alcoholic fatty liver disease (NAFLD)","volume":"398","author":"Selim","year":"2025","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"issue":"5","key":"10.1016\/j.jep.2025.120292_bib65","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrendo.2018.10","article-title":"Direct effects of thyroid hormones on hepatic lipid metabolism","volume":"14","author":"Sinha","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"10.1016\/j.jep.2025.120292_bib66","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1186\/s12885-024-12316-4","article-title":"The hippo pathway terminal effector TAZ\/WWTR1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells","volume":"24","author":"Slaninova","year":"2024","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.jep.2025.120292_bib67","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3831\/KPI.2016.19.002","article-title":"Historical medical value of Donguibogam","volume":"19","author":"Song","year":"2016","journal-title":"J. Pharmacopuncture"},{"issue":"8","key":"10.1016\/j.jep.2025.120292_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005465","article-title":"YAP1 exerts its transcriptional control via TEAD-mediated activation of enhancers","volume":"11","author":"Stein","year":"2015","journal-title":"PLoS Genet."},{"key":"10.1016\/j.jep.2025.120292_bib69","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.freeradbiomed.2021.10.017","article-title":"Role of vitamin E in the treatment of non-alcoholic steatohepatitis","volume":"177","author":"Sumida","year":"2021","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.jep.2025.120292_bib70","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41401-020-0472-9","article-title":"AMPK activator C24 inhibits hepatic lipogenesis and ameliorates dyslipidemia in HFHC diet-induced animal models","volume":"42","author":"Sun","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"issue":"3","key":"10.1016\/j.jep.2025.120292_bib71","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jphs.2018.07.003","article-title":"Inhibition of nuclear factor-kappaB p65 phosphorylation by 3,4-dihydroxybenzalacetone and caffeic acid phenethyl ester","volume":"137","author":"Takakura","year":"2018","journal-title":"J. Pharmacol. Sci."},{"issue":"12","key":"10.1016\/j.jep.2025.120292_bib73","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJMc1006581","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"363","author":"Violi","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"716","key":"10.1016\/j.jep.2025.120292_bib74","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adi0759","article-title":"Found in translation-fibrosis in metabolic dysfunction-associated steatohepatitis (MASH)","volume":"15","author":"Wang","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jep.2025.120292_bib75","article-title":"Exploring the lipid-lowering effects of cinnamic acid and cinnamaldehyde from the perspective of the gut microbiota and metabolites","author":"Wang","year":"2025","journal-title":"Food Funct."},{"issue":"6","key":"10.1016\/j.jep.2025.120292_bib76","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.cmet.2016.09.016","article-title":"Hepatocyte TAZ\/WWTR1 promotes inflammation and fibrosis in nonalcoholic steatohepatitis","volume":"24","author":"Wang","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.jep.2025.120292_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2020.111148","article-title":"Anti-obesity effect of trans-cinnamic acid on HepG2 cells and HFD-fed mice","volume":"137","author":"Wang","year":"2020","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.jep.2025.120292_bib78","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12935-019-0796-z","article-title":"The hippo signaling effector WWTR1 is a metastatic biomarker of gastric cardia adenocarcinoma","volume":"19","author":"Wei","year":"2019","journal-title":"Cancer Cell Int."},{"issue":"13","key":"10.1016\/j.jep.2025.120292_bib79","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1016\/j.celrep.2017.03.011","article-title":"Liver-specific activation of AMPK prevents steatosis on a high-fructose diet","volume":"18","author":"Woods","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.jep.2025.120292_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112582","article-title":"GDF-15, a future therapeutic target of glucolipid metabolic disorders and cardiovascular disease","volume":"146","author":"Xiao","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.jep.2025.120292_bib81","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41420-024-02168-z","article-title":"Targeting cell death in NAFLD: mechanisms and targeted therapies","volume":"10","author":"Xu","year":"2024","journal-title":"Cell Death Discov."},{"issue":"10","key":"10.1016\/j.jep.2025.120292_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240616","article-title":"Hypolipidemic effect of Alisma orientale (Sam.) Juzep on gut microecology and liver transcriptome in diabetic rats","volume":"15","author":"Xu","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jep.2025.120292_bib83","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.apsb.2019.11.017","article-title":"Herbal drug discovery for the treatment of nonalcoholic fatty liver disease","volume":"10","author":"Yan","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.jep.2025.120292_bib84","first-page":"1","article-title":"Protective effects of cinnamic acid against hyperglycemia induced oxidative stress and inflammation in HepG2 cells","volume":"12","author":"Yazdi","year":"2023","journal-title":"Rep. Biochem. Mol. Biol."},{"issue":"1","key":"10.1016\/j.jep.2025.120292_bib85","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11033-024-10177-5","article-title":"YAP\/TAZ as master regulators in liver regeneration and disease: insights into mechanisms and therapeutic targets","volume":"52","author":"Ye","year":"2024","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.jep.2025.120292_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2022.146973","article-title":"Yin-chen Wu-ling powder alleviate cholestatic liver disease: network pharmacological analysis and experimental validation","volume":"851","author":"You","year":"2023","journal-title":"Gene"},{"key":"10.1016\/j.jep.2025.120292_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114768","article-title":"Alisol B alleviates MASLD by activating liver autophagy and fatty acid oxidation via Ces2a","volume":"157","author":"Zhang","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jep.2025.120292_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110768","article-title":"Farnesoid X receptor activation is required for the anti-inflammatory and anti-oxidative stress effects of Alisol B 23-acetate in carbon tetrachloride-induced liver fibrosis in mice","volume":"123","author":"Zhang","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jep.2025.120292_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155629","article-title":"Rhizoma Alismatis decoction improved mitochondrial dysfunction to alleviate SASP by enhancing autophagy flux and apoptosis in hyperlipidemia acute pancreatitis","volume":"129","author":"Zhang","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jep.2025.120292_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117538","article-title":"Deciphering the enigma between low bioavailability and high anti-hepatic fibrosis efficacy of Yinchen wuling powder based on drug metabolism and network pharmacology","volume":"321","author":"Zhang","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.jep.2025.120292_bib91","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jep.2013.06.031","article-title":"Traditional uses, phytochemistry, pharmacology, pharmacokinetics and quality control of Polyporus umbellatus (Pers.) fries: a review","volume":"149","author":"Zhao","year":"2013","journal-title":"J. Ethnopharmacol."},{"issue":"7","key":"10.1016\/j.jep.2025.120292_bib92","first-page":"6147","article-title":"Poria cocos polysaccharides improve alcoholic liver disease by interfering with ferroptosis through NRF2 regulation","volume":"16","author":"Zhou","year":"2024","journal-title":"Aging (Albany NY)"}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874125009821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874125009821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T11:45:51Z","timestamp":1757677551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874125009821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":91,"alternative-id":["S0378874125009821"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2025.120292","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Injinoryeong-San attenuates metabolic dysfunction-associated steatohepatitis via regulation of YAP\/TAZ-signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2025.120292","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120292"}}